drugset / Trial / NCT06199154

Induction of Labor in Morbidly Obese Patients

NCT06199154

Phase 0 Recruiting 162 enrolled University of Maryland, Baltimore
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI \>40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vaginal delivery in this population can improve, then surgical morbidity can be reduced in these patients.

Timeline

Start
2024-07-15
Primary completion
2026-05
Completion
2026-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 25 ug Other
Subject Misoprostol Other / unclassified 50 ug Other